UBS rates ORI as Downgrade to Sell from Neutral
UBS is incorporating increasing headwinds for the Australasian explosives business into forecasts. This results in an earnings per share cut of 4-5% in FY14-16. On current multiples UBS believes the stock looks expensive relative to its cyclical industrial peers.
As near-term risk/reward is skewed to the downside, given the leverage to global coal markets, the broker reduces the rating to Sell from Neutral. Target is lowered to $19.50 from $21.67.
- Forums
- ASX - By Stock
- UBS rates ORI as Downgrade to Sell from Neutral
ORI
orica limited
Add to My Watchlist
0.33%
!
$21.31

UBS rates ORI as Downgrade to Sell from Neutral UBS is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$21.31 |
Change
-0.070(0.33%) |
Mkt cap ! $10.17B |
Open | High | Low | Value | Volume |
$21.23 | $21.39 | $21.09 | $8.113M | 381.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 45064 | $23.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.18 | 56319 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 149 | 23.010 |
2 | 1716 | 22.800 |
8 | 23997 | 22.590 |
1 | 119 | 22.390 |
12 | 23176 | 22.380 |
Price($) | Vol. | No. |
---|---|---|
19.180 | 13319 | 1 |
19.930 | 24 | 1 |
19.950 | 2615 | 1 |
20.030 | 5840 | 4 |
20.060 | 545 | 2 |
Last trade - 15.59pm 01/08/2025 (20 minute delay) ? |
Featured News
ORI (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online